Nucleic Acids Research Advance Access originally published online on September 6, 2008
Nucleic Acids Research 2009 37(Database issue):D239-D243; doi:10.1093/nar/gkn570
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2009, Vol. 37, Database issue D239-D243
© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article appears in the following Nucleic Acids Research issue: Database issue [View the issue table of contents]
Articles |
The Degradome database: mammalian proteases and diseases of proteolysis
Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain
*To whom correspondence should be addressed. Tel: +34 985 104201; Fax: +34 985 103564; Email: clo{at}uniovi.es
Received July 28, 2008. Accepted August 21, 2008.
The degradome is defined as the complete set of proteases present in an organism. The recent availability of whole genomic sequences from multiple organisms has led us to predict the contents of the degradomes of several mammalian species. To ensure the fidelity of these predictions, our methods have included manual curation of individual sequences and, when necessary, direct cloning and sequencing experiments. The results of these studies in human, chimpanzee, mouse and rat have been incorporated into the Degradome database, which can be accessed through a web interface at http://degradome.uniovi.es. The annotations about each individual protease can be retrieved by browsing catalytic classes and families or by searching specific terms. This web site also provides detailed information about genetic diseases of proteolysis, a growing field of great importance for multiple users. Finally, the user can find additional information about protease structures, protease inhibitors, ancillary domains of proteases and differences between mammalian degradomes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. List, P. Kosa, R. Szabo, A. L. Bey, C. B. Wang, A. Molinolo, and T. H. Bugge Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway Am. J. Pathol., October 1, 2009; 175(4): 1453 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Bugge, T. M. Antalis, and Q. Wu Type II Transmembrane Serine Proteases J. Biol. Chem., August 28, 2009; 284(35): 23177 - 23181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Szabo, J. P. Hobson, K. Christoph, P. Kosa, K. List, and T. H. Bugge Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice Development, August 1, 2009; 136(15): 2653 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Ramsay, J. D. Hooper, A. R. Folgueras, G. Velasco, and C. Lopez-Otin Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis Haematologica, June 1, 2009; 94(6): 840 - 849. [Abstract] [Full Text] [PDF]
|
|